Revolution Medicines

Director, Medical Science Liaison, Oncology (Dallas, AR, LA, OK, MS)

Remote (United States) · Director · Full-time

Sponsorship not specified$236k-$259kDetected 22 hours ago

ComplianceAR/VRClinical TrialsClinical ResearchResearchCommunicationPublic Speaking

About the role

Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions.
Stay current with scientific literature, emerging research, and competitive landscape.
Adhere to Revolution Medicines Core Values and policies.

Support the synthesis and communicate scientific insights from KOLs to relevant internal teams.
The candidate should be located within an hour drive of a major airport.

8+ years experience as an MSL or in a similar role within the pharmaceutical or biotech industry.

Doctoral degree in scientific or medical discipline.
3+ years experience as a MSL working in the GI cancer disease state area.
Strong understanding of clinical research methodologies and drug development processes.
Knowledge and experience within the oncology therapeutic area.
Excellent verbal and written communication skills.
Proven ability to analyze and synthesize scientific information effectively.
Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences.
Self-directed and able to thrive in a fast-paced and dynamic environment.
Willingness to travel up to 60% of time.
Preferred experience in gastrointestinal cancers.
Experience with both early and late stage clinical assets as well as approved therapies.
#LI-VN1 #LI-Remote

$236,000 - $259,000 USD
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.

Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge.
Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities.
Establish credibility as a scientific expert and resource for internal stake holders, providing medical and scientific support for products and therapeutic areas.
Collaborate cross-functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
We are seeking a highly motivated and experienced professional to join our team as a GI Medical Science Liaison.

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.